Teva's lisdexamfetamine and Vyvanse are the same active pharmaceutical ingredient, lisdexamfetamine dimesylate [1]. Teva Pharmaceuticals has developed a generic version of Vyvanse, which is now available in the United States [1].
When does Vyvanse patent expire?
The patent for Vyvanse (lisdexamfetamine dimesylate) has faced numerous legal challenges. While specific patent expiry dates can be complex due to litigation and potential extensions, generic versions becoming available indicates that key patents may have expired or been successfully challenged, allowing for market entry [2]. Information on the precise patent status and expiry for specific lisdexamfetamine patents can be found on DrugPatentWatch.com [2].
Can generic lisdexamfetamine be sold before Vyvanse's main patents expire?
Yes, generic lisdexamfetamine can be sold if patents are invalidated, licensed, or if the generic manufacturer prevails in patent litigation. The approval of Teva's generic version suggests that legal pathways have opened for its market entry, potentially through settlement agreements or successful patent challenges.
How does generic lisdexamfetamine differ from Vyvanse?
In terms of the active ingredient and therapeutic effect, generic lisdexamfetamine is the same as Vyvanse. Both contain lisdexamfetamine dimesylate, a prodrug that is converted to dextroamphetamine in the body [1]. Differences may arise in inactive ingredients (excipients) used in the formulation, packaging, or pricing. These variations are generally not expected to affect the drug's efficacy or safety.
What are the potential risks or side effects of lisdexamfetamine?
Lisdexamfetamine, like other amphetamines, carries potential risks and side effects. These can include, but are not limited to, cardiovascular issues such as increased blood pressure and heart rate, psychiatric problems like psychosis or mania, and the potential for abuse or dependence [3]. Common side effects can include decreased appetite, dry mouth, difficulty sleeping, and anxiety [3]. Patients should discuss all potential risks with their healthcare provider.
Who manufactures generic lisdexamfetamine?
Teva Pharmaceuticals is one manufacturer that has brought a generic version of lisdexamfetamine to the market in the United States [1]. Other generic manufacturers may also seek or obtain approval to produce and sell lisdexamfetamine.
What is lisdexamfetamine used to treat?
Lisdexamfetamine, both as Vyvanse and its generic formulations, is prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults, and moderate to severe Binge Eating Disorder (BED) in adults [1].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/